NASDAQ | TSX: ACB Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million1 Australian market. Transaction is expected to be immediately accretive to Adjusted EBITDA2 and accelerate the Company's plan for Positive Free Cash Flow2 generation in calendar 2024. EDMONTON, AB, Feb. 8, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) ...